25+
active clinics
adopting BnTRx workflows
BnTRx for clinics
Make a stress and cost-free change to your PBS botulinum toxin clinic today
No need to rebuild your process - shed the paperwork and complexity. A dedicated pharmacy and software team are here to help.
15,000+
orders processed
through the platform since launch
5,000+
patients supported
across treatment and co-payment workflows
BnTRx process flow
- 1
Patient registers once for co-payment (no repeat forms).
- 2
Prescription is uploaded in BnTRx with minimal admin handling.
- 3
Vial use is auto-tabulated for clearer stock visibility.
- 4
Vials are delivered to your clinic at your requested rate and timing.
- Developed and tested by botulinum toxin clinical and commercial experts.
- eScript-compatible, supporting a fully paperless option where suitable.
Prescription Upload
Upload scripts digitally in seconds, link them to the patient record, and avoid postal delays.
Automated Re-ordering
Usage-driven automation prepares repeat orders without your team manually contacting multiple suppliers.
No Fuss Co-payment
Capture consent and payment details once, store them securely, and process charges after treatment.
Stock Control System
See what is in-clinic, on order, and already used with clear, real-time inventory visibility.
Trusted by Clinics
Active across specialist clinics in Australia
BnTRx is in active use across specialist neurology and treatment clinics, supporting botulinum toxin workflows from prescription through to stock reconciliation.
- Australian-owned and developed by Integra Medical Group
- Built and tested in busy Australian clinic environments
- Supports PBS prescription, co-payment and stock workflows
- Designed for practical onboarding across clinic and pharmacy teams
- Contributed to adoption across 25+ active clinics, processing 15,000+ orders for 5,000+ patients since launch
About
BnTRx has been developed by Integra Medical Group (IMG). IMG is uniquely placed to understand and develop solutions for busy clinics that administer botulinum toxin. This is due to extensive clinic-based testing within the Australian setting, integrating the various requirements for PBS prescription processing, stock re-ordering and tracking, as well as patient co-payment. BnTRx was purposefully built to alleviate administration time and will facilitate significantly less filling and handling of paper forms and much greater automation and transparency in stock management. IMG is the developer and owner of BnTx Interact software for clinics that administer botulinum toxin for therapeutic purposes. An anatomical patient recording system that contains assessment and treatment fields as well as national data, BnTx Interact has been operating in Australian clinics for over 10 years.
Leadership experience relevant to BnTRx delivery
Prof Con Yiannikas
Director, Integra Medical Group
Prof Con Yiannikas is a Director at Integra Medical Group, Clinical Professor at the University of Sydney, and a practising neurologist at RNSH, Concord Hospital, and Innerwest Neurology. His specialist clinical perspective helps shape BnTRx around the operational realities of neurological clinics, including records, prescribing, and stock tracking.
Anthony Avvenevole
Director, Integra Medical Group
Anthony Avvenevole is a Director at Integra Medical Group with over 18 years in medtech leadership, including roles at Allergan, LivaNova, Invetech, and Neurology Interact. His experience supports practical rollout and adoption of BnTRx across clinical, pharmacy, and supply workflows.